Back to Search
ANTHONY PALUMBO, PHD LICSW
PHD LICSW
Clinical Social Worker
NPI: 1558348920Individual
Specialties, Licenses & Credentials
Clinical Social WorkerPrimary
Social Worker — Clinical
Code: 1041C0700X
1016758(MA)
Research & Publications (20)
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.
PMID 19406725·Clin Lymphoma Myeloma·2009
3-trial
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
PMID 19494840·Leukemia·2009
6-review
Coronary calcium score as gatekeeper for 64-slice computed tomography coronary angiography in patients with chest pain: per-segment and per-patient analysis.
PMID 19387651·Eur Radiol·2009
4-observational
Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
PMID 18774632·Blood Rev·2009
6-review
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
PMID 18094721·Leukemia·2008
6-review
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
PMID 18505783·Blood·2008
2-rct
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.
PMID 18326520·Ann Oncol·2008
3-trial
Update on recent developments for patients with newly diagnosed multiple myeloma.
PMID 18837878·Ann N Y Acad Sci·2008
3-trial
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
PMID 17785703·J Clin Oncol·2007
3-trial
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.
PMID 17594696·Cancer·2007
8-other
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
PMID 17148584·Blood·2007
3-trial
Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.
PMID 16796778·Clin Lymphoma Myeloma·2006
3-trial
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
PMID 16530576·Lancet·2006
4-observational
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
PMID 16519697·Eur J Haematol·2006
3-trial
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant.
PMID 16191088·Eur J Haematol·2005
4-observational
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
PMID 16116606·Cancer·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 18 GRAHAM ST
WAREHAM, MA 02571 - Phone
- (508) 295-4529
Quick Facts
- NPI
- 1558348920
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile